Girish Mahajan (Editor)

A 796,260

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
CAS Number  895155-26-7
ChemSpider  9759290
ECHA InfoCard  100.233.198
Molar mass  354.485 g/mol
PubChem CID  11584525
ChEMBL  CHEMBL262865
Formula  C22H30N2O2
A-796,260 httpsuploadwikimediaorgwikipediacommonsthu

A-796,260 is a drug developed by Abbott Laboratories that acts as a potent and selective cannabinoid CB2 receptor agonist. Replacing the aromatic 3-benzoyl or 3-naphthoyl group found in most indole derived cannabinoids with the 3-tetramethylcyclopropylmethanone group, imparts significant selectivity for CB2, and A-796,260 was found to be a highly selective CB2 agonist with little affinity for CB1, having a CB2 Ki of 4.6 nM vs 945 nM at CB1. It has potent analgesic and anti-inflammatory actions in animal models, being especially effective in models of neuropathic pain, but without producing cannabis-like behavioral effects.

Legal Status

As of October 2015 A-796,260 is a controlled substance in China.

References

A-796,260 Wikipedia


Similar Topics
Sture Allén
Rosario Ortiz Yeladaqui
Aïyb Dieng
Topics
 
B
i
Link
H2
L